WebMar 31, 2024 · SEC Filings Document Details Form 10-Q Filing Date May 3, 2024 Document Date Mar 31, 2024 Form Description Quarterly report which provides a continuing view of … WebSep 27, 2024 · The companies will share development costs associated with global and U.S. -specific trials for all agreed upon trials at a rate of 55% ( Incyte) and 45% (Syndax), with Incyte responsible for 100% of future development costs for trials that are specific to ex- …
Incyte Corp (INCY) 8-K Earnings Release - Feb 2024
WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … WebHere, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Incyte's ongoing operational relationships across important fundamental and technical indicators. Latest Incyte Corporation Q4 2024 Earnings Call Transcript INCY 81.24 0.74 Low 80.29 High 81.49 Alpha 0.0623 Beta 0.1 north korea threatens guam
Pacer Advisors Inc. Sells 7,945 Shares of Incyte Co. (NASDAQ:INCY)
WebThis page has all the financial reports filed by INCYTE CORP including the common sec filings such as Annual reports 10K, Quarterly reports 10Q, Insider trading reports on Form … WebApr 5, 2024 · INCY traded up $1.14 on Wednesday, hitting $73.79. 266,480 shares of the company's stock were exchanged, compared to its average volume of 1,653,264. The company has a current ratio of 3.54, a quick ratio of 3.50 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $77.16 and a two-hundred day moving … WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home … north korea through the looking glass